R&D News | pharmaphorum

News

lightbulb with AI label on white brain inside, against purple background

Novo taps Anthropic's Claude AI for drug discovery

Novo adds Anthropic AI models and Claude Science to its drug discovery toolkit in a bid to become "the world's most AI-driven healthcare company."

News

Legend Biotech names ex-Novartis exec as CEO

Cell therapy developer Legend Biotech has named Ingrid Zhang as its new chief executive, ending its search for new leadership.

News

TikTok parent ByteDance raises cash for drug AI spinout Anew

Chinese tech giant ByteDance, best known as the parent of TikTok, has completed a $290m financing for its AI drug discovery spinout Anew Labs.

News

AI spots drugs that may be repurposed for priority pathogen

Researchers have used AI algorithms to sift through thousands of drug molecules and identify some with activity against problem pathogen S pneumoniae.

News

FDA unveils framework for its expedited IND pilot

The FDA has published the design of its expedited Investigational New Drug pilot, part of a plan to restore US competitiveness in clinical research.

News

Electra sets terms for IPO, hoping to raise up to $347m

Electra Therapeutics has moved ahead with plans for an IPO, seeking to raise funds for its drug for the rare and life-threatening disease sHLH.

Novo taps Anthropic's Claude AI for drug discovery

Legend Biotech names ex-Novartis exec as CEO

TikTok parent ByteDance raises cash for drug AI spinout Anew

AI spots drugs that may be repurposed for priority pathogen

FDA unveils framework for its expedited IND pilot

Electra sets terms for IPO, hoping to raise up to $347m

AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks